These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 15658543

  • 1. [Antiphospholipid syndrome and exogenic risk factors in thromboses].
    Tikhonova TL, Mach ES, Shirokova IE, Reshetniak TM.
    Ter Arkh; 2004; 76(11):71-4. PubMed ID: 15658543
    [Abstract] [Full Text] [Related]

  • 2. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 3. [The role of hyperhomocysteinemia in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM, Shirokova IE, Lisitskaia TL.
    Ter Arkh; 2006 Jun; 78(6):24-30. PubMed ID: 16881359
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thrombosis in systemic lupus erythematosus: risk and protection.
    Burgos PI, Alarcón GS.
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1541-9. PubMed ID: 19954316
    [Abstract] [Full Text] [Related]

  • 13. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
    Ruiz-Irastorza G, Egurbide MV, Ugalde J, Aguirre C.
    Arch Intern Med; 2004 Jan 12; 164(1):77-82. PubMed ID: 14718326
    [Abstract] [Full Text] [Related]

  • 14. Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome?
    Weber M, Hayem G, De Bandt M, Seifert B, Palazzo E, Roux S, Kahn MF, Meyer O.
    J Rheumatol; 1999 Oct 12; 26(10):2131-6. PubMed ID: 10529128
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.